2022
DOI: 10.1016/j.phyplu.2022.100259
|View full text |Cite
|
Sign up to set email alerts
|

Hepatocellular carcinoma and miRNAs: An in silico approach revealing potential therapeutic targets for polyphenols

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 84 publications
0
2
0
Order By: Relevance
“…MicroRNA (miRNA) is a non-coding small fragment (approximately 20–22 nucleotides) single-stranded RNA molecule participating in various physiological processes in cells. , MiRNA let-7 is one of the earliest discovered miRNA families with 13 members in humans of which the miRNA let-7a is the earliest identified oncogene fragment . Numerous pathological studies have shown that the abnormal expression of miRNA let-7a in tumor cells and serum is correlated to many cancers, such as hepatocellular carcinoma (HCC), breast cancer, and pancreatic cancer, making miRNA let-7a one of crucial cancer biomarkers. At present, a variety of methods have been developed to detect miRNA let-7a, such as electrochemiluminescence, , fluorescence assays, and electrochemical methods. , Compared to the other methods, the electrochemical biosensing technology has the advantages of simpleness, low cost, and high sensitivity, which are more conducive to the establishment of practical analytical devices.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…MicroRNA (miRNA) is a non-coding small fragment (approximately 20–22 nucleotides) single-stranded RNA molecule participating in various physiological processes in cells. , MiRNA let-7 is one of the earliest discovered miRNA families with 13 members in humans of which the miRNA let-7a is the earliest identified oncogene fragment . Numerous pathological studies have shown that the abnormal expression of miRNA let-7a in tumor cells and serum is correlated to many cancers, such as hepatocellular carcinoma (HCC), breast cancer, and pancreatic cancer, making miRNA let-7a one of crucial cancer biomarkers. At present, a variety of methods have been developed to detect miRNA let-7a, such as electrochemiluminescence, , fluorescence assays, and electrochemical methods. , Compared to the other methods, the electrochemical biosensing technology has the advantages of simpleness, low cost, and high sensitivity, which are more conducive to the establishment of practical analytical devices.…”
Section: Introductionmentioning
confidence: 99%
“…1,2 MiRNA let-7 is one of the earliest discovered miRNA families with 13 members in humans of which the miRNA let-7a is the earliest identified oncogene fragment. 3 Numerous pathological studies have shown that the abnormal expression of miRNA let-7a in tumor cells and serum is correlated to many cancers, such as hepatocellular carcinoma (HCC), 4 breast cancer, 5 and pancreatic cancer, 6 making miRNA let-7a one of crucial cancer biomarkers. At present, a variety of methods have been developed to detect miRNA let-7a, such as electrochemiluminescence, 7,8 fluorescence assays, 9 and electrochemical methods.…”
Section: Introductionmentioning
confidence: 99%